XML 52 R36.htm IDEA: XBRL DOCUMENT v3.25.0.1
Share-Based Payment Arrangements (Tables)
 12 Months Ended
Dec. 31, 2024
Share-based Payment Arrangements [Abstract]  
Schedule of Number and Weighted Average Exercise Prices of Share Options The number and weighted average exercise prices (in USD) of share options are as follows:
   Weighted average exercise price   Number of options 
   2024   2023   2022   2024   2023   2022 
Outstanding on January 1   0.46    0.52    0.97    19,218,783    18,468,235    7,751,303 
Expired and forfeited during the year   0.84    0.54    0.82    (2,004,460)   (2,026,452)   (418,068)
Granted during the year   0.037    0.19    0.28    3,150,000    2,777,000    11,135,000 
Outstanding on December 31   0.36    0.46    0.52    20,364,323    19,218,783    18,468,235 
Exercisable on December 31   0.45    0.62    0.97    14,420,406    10,923,032    6,144,318 
Schedule of Number of RSUs The number of RSUs are as follows:
   Number of RSUs 
   2024   2023 
Outstanding at January 1   5,770,750    7,857,917 
Granted during the year   3,150,000    2,777,000 
Forfeited during the year   (859,584)   (1,187,292)
Vested during the year   (3,142,249)   (3,676,875)
Outstanding at December 31   4,918,917    5,770,750 
Schedule of Assumptions were Used The following assumptions were used:
   2024   2023 
Share Price - USD   0.036    0.160-0.226 
Exercise price - USD   0.037    0.19 -0.2 
Expected volatility (%)   95.93    93.54-96.04 
Expected duration (years)   2-2.8    2-5 
Dividend yield (%)   
-
    
-
 
Risk free rate interest rate (%)   3.88%   3.56%-4.31% 
Schedule of Expenses Recognized in the Consolidated Financial Statements Expenses recognized in the consolidated financial statements:
   For the year ended December 31, 
   2024   2023   2022 
   USD thousands 
Research and development expenses   117    768    768 
General and administrative expenses   465    1,107    1,644 
                
Total share-based expense recognized   582    1,875    2,412